Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $69.47M.
ENTERPRISE VALUE (EV)
$69.47M
Humacyte, Inc.
Market Cap
$84.52M
Enterprise Value (EV)
$69.47M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Humacyte, Inc. (HUMA) | $84.52M | $69.47M |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.44M | $50.94M |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.97M | $90.63M |
| LENSAR Inc (LNSR)vs › | $83.92M | $72.73M |
| Citius Oncology, Inc. (CTOR)vs › | $85.53M | $79.18M |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $85.60M | $46.30M |
| CareCloud, Inc. (CCLD)vs › | $87.11M | $127.73M |
| Pulmonx Corporation (LUNG)vs › | $81.10M | $81.46M |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | $79.89M |
| Conexeu Sciences Inc. (CNXU)vs › | $88.84M | N/A |
Market Cap
$84.52M
Total Debt
$35.44M
Cash
$50.50M
Enterprise Value
$69.47M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
